Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:FCHS NASDAQ:IVF OTCMKTS:TOMDF OTCMKTS:ZICX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFCHSFirst Choice Healthcare Solutions$0.01+8.9%$0.01$0.00▼$0.01$200K0.88891 shs911 shsIVFINVO Fertility$0.83+1.1%$1.27$0.74▼$17.04$1.77M2.04576,965 shs587,107 shsTOMDFTodos Med$0.00$0.00▼$0.00N/A-0.03500,000 shs500,000 shsZICXZicix$0.00$0.00$0.00▼$0.00$550K1.7854,443 shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFCHSFirst Choice Healthcare Solutions+9.12%+8.93%-32.22%+3.46%+1.67%IVFINVO Fertility+2.24%-4.55%-37.89%+81,989,900.00%+81,989,900.00%TOMDFTodos Med0.00%0.00%0.00%0.00%0.00%ZICXZicix0.00%0.00%0.00%-14.29%+20.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFCHSFirst Choice Healthcare Solutions0.3379 of 5 stars0.03.00.00.01.31.70.0IVFINVO FertilityN/AN/AN/AN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/AN/AN/AN/AZICXZicixN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFCHSFirst Choice Healthcare Solutions 0.00N/AN/AN/AIVFINVO Fertility 0.00N/AN/AN/ATOMDFTodos Med 0.00N/AN/AN/AZICXZicix 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFCHSFirst Choice Healthcare Solutions$30K6.70N/AN/A($0.99) per share-0.01IVFINVO Fertility$6.53M0.27N/AN/A($29.86) per share-0.03TOMDFTodos MedN/AN/AN/AN/AN/AN/AZICXZicixN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFCHSFirst Choice Healthcare Solutions-$3.85M-$0.13N/A∞N/AN/AN/A-96.09%N/AIVFINVO Fertility-$9.10M-$34.06N/A∞N/A-377.73%N/A-88.18%N/ATOMDFTodos MedN/AN/A0.00N/AN/AN/AN/AN/AN/AZICXZicixN/AN/A0.00∞N/AN/AN/AN/AN/ALatest ZICX, IVF, TOMDF, and FCHS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025IVFINVO FertilityN/A-$12.53N/A-$12.53N/A$1.64 million5/15/2025Q1 2025FCHSFirst Choice Healthcare SolutionsN/A-$0.04N/A-$0.04N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFCHSFirst Choice Healthcare SolutionsN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/ATOMDFTodos MedN/AN/AN/AN/AN/AZICXZicixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioFCHSFirst Choice Healthcare SolutionsN/AN/AN/AIVFINVO FertilityN/A0.080.07TOMDFTodos MedN/AN/AN/AZICXZicixN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFCHSFirst Choice Healthcare SolutionsN/AIVFINVO Fertility12.02%TOMDFTodos MedN/AZICXZicixN/AInsider OwnershipCompanyInsider OwnershipFCHSFirst Choice Healthcare Solutions30.81%IVFINVO Fertility0.57%TOMDFTodos MedN/AZICXZicixN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFCHSFirst Choice Healthcare Solutions20732.96 million22.80 millionNot OptionableIVFINVO Fertility102.16 million2.15 millionN/ATOMDFTodos Med7N/AN/ANot OptionableZICXZicix2916.02 millionN/ANot OptionableZICX, IVF, TOMDF, and FCHS HeadlinesRecent News About These CompaniesWhat to buy and skip during Amazon’s Prime Big Deal Days, according to expertsOctober 8, 2023 | nbcnews.comBest art supplies stores to shop online in the UKSeptember 22, 2023 | standard.co.ukSZicix Corporation (ZICX) Stock Historical Prices & Data - Yahoo FinanceSeptember 8, 2023 | finance.yahoo.com10 best die cutting machines for craft aficionadosAugust 31, 2023 | msn.comZICIX+CTIP-FII RECEIVES NOTICE TO PROCEED FROM PROJECT OWNER TO START THE $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEYMarch 6, 2023 | finance.yahoo.comZICIX AND ASIA BASED CONSTRUCTION GROUP AGREES TO FORM A CONSTRUCTION MANAGEMENT COMPANYNovember 28, 2022 | finance.yahoo.comZICIX + CTIP-FII RECEIVES ORDER FROM CITY OF KAKATA, LIBERIA TO BUY PASSENGER BUSESOctober 17, 2022 | finance.yahoo.comZICIX+CTIP-FII UPDATES STOCKHOLDERS ON PROJECTS ON-GOINGSeptember 6, 2022 | finance.yahoo.comZICIX owned CTIP-FII Receives Award from Liberia...August 24, 2022 | benzinga.comZICIX owned CTIP-FII Receives Award from Liberia's Ministry of Public Works for Road ProjectAugust 22, 2022 | tmcnet.comZICIX owned CTIP-FII Receives Award from Liberia’s Ministry of Public Works for Road ProjectAugust 22, 2022 | finance.yahoo.comZICIX Receives Health Ministry's Support for Hospital Project in SenegalAugust 13, 2022 | stockhouse.comZICIX OPERATING COMPANY SIGNS DEVELOPMENT CONTRACT TO BUILD HOSPITALSAugust 12, 2022 | finance.yahoo.comZICIX Finalizes Acquisition of CTIP-FIIAugust 12, 2022 | finance.yahoo.comZICIX AND CTIP-FII JOINS DEVELOPMENT OF P2A HOSPITAL PROJECT IN SENEGALAugust 12, 2022 | finance.yahoo.comZICIX Corporation to Develop P2A Hospital Project in SenegalAugust 12, 2022 | finance.yahoo.comZICIX Receives Health Ministry’s Support for Hospital Project in SenegalAugust 12, 2022 | finance.yahoo.comMedia Sentiment Over TimeZICX, IVF, TOMDF, and FCHS Company DescriptionsFirst Choice Healthcare Solutions OTCMKTS:FCHS$0.0061 +0.00 (+8.93%) As of 07/16/2025 03:19 PM EasternFirst Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.INVO Fertility NASDAQ:IVF$0.83 +0.01 (+1.15%) As of 04:00 PM EasternNAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).Todos Med OTCMKTS:TOMDFTodos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.Zicix OTCMKTS:ZICX$0.0006 0.00 (0.00%) As of 07/16/2025Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
